TwinBeech Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-277,047
| Closed | -$2.8M | – | 708 |
|
|
2022
Q4 | $2.8M | Buy |
277,047
+63,879
| +30% | +$645K | 0.05% | 367 |
|
|
2022
Q3 | $4.78M | Buy |
+213,168
| New | +$4.78M | 0.13% | 200 |
|
|
2022
Q2 | – | Sell |
-53,897
| Closed | -$2.09M | – | 568 |
|
|
2022
Q1 | $2.09M | Buy |
+53,897
| New | +$2.09M | 0.09% | 240 |
|
|
2021
Q4 | – | Sell |
-34,427
| Closed | -$2.04M | – | 640 |
|
|
2021
Q3 | $2.04M | Buy |
34,427
+19,861
| +136% | +$1.18M | 0.14% | 217 |
|
|
2021
Q2 | $1.26M | Buy |
14,566
+7,066
| +94% | +$613K | 0.15% | 186 |
|
|
2021
Q1 | $618K | Buy |
+7,500
| New | +$618K | 0.09% | 267 |
|